-
Mashup Score: 23Association of Immunotherapy Duration With Overall Survival in Advanced Non–Small Cell Lung Cancer - 2 month(s) ago
This cohort study of advanced non–small cell lung cancer patients assesses practice patterns surrounding immunotherapy discontinuation at 2 years and evaluates the association of duration of therapy with overall survival.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 24Lauzon - 3 month(s) ago
Media Inquires: email: Press@FansMeetIdols.com phone: (404) 999-5149Fans Meet Idols LLC – Copyright 2024PrivacyTerms
Source: www.fansmeetidols.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 24Lauzon - 3 month(s) ago
Media Inquires: email: Press@FansMeetIdols.com phone: (404) 999-5149Fans Meet Idols LLC – Copyright 2024PrivacyTerms
Source: www.fansmeetidols.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 28How Scientific Publishers’ Extreme Fees Put Profit Over Progress - 3 month(s) ago
On April 17, the premier journal NeuroImage’s entire editorial team, comprising more than 40 scientists, resigned over the “unethical fees” charged by the journal’s academic pub lisher, Elsevier. With more than $2 billion in annual revenue, the publisher’s profit margin approaches 40 percent — rivaling that of Apple and Google. “Elsevier has become kind of like the poster child for evil publishing companies,” said neuroscientist Kristen Kennedy, one of the recently resigned senior editors. Kennedy relies
Source: www.thenation.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 28How Scientific Publishers’ Extreme Fees Put Profit Over Progress - 3 month(s) ago
On April 17, the premier journal NeuroImage’s entire editorial team, comprising more than 40 scientists, resigned over the “unethical fees” charged by the journal’s academic pub lisher, Elsevier. With more than $2 billion in annual revenue, the publisher’s profit margin approaches 40 percent — rivaling that of Apple and Google. “Elsevier has become kind of like the poster child for evil publishing companies,” said neuroscientist Kristen Kennedy, one of the recently resigned senior editors. Kennedy relies
Source: www.thenation.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 6
Disney, Apple and Lionsgate halted marketing on X, formerly Twitter, as Elon Musk faced a furor over antisemitic abuse on his social media platform.
Source: www.nytimes.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 23Association of Immunotherapy Duration With Overall Survival in Advanced Non–Small Cell Lung Cancer - 6 month(s) ago
This cohort study of advanced non–small cell lung cancer patients assesses practice patterns surrounding immunotherapy discontinuation at 2 years and evaluates the association of duration of therapy with overall survival.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet-
Hope the retrospective data evaluated by @LovaSunMD & colleagues was also featured in discussion. https://t.co/lXFJNM79V9 Not prospective data, but we're not going to have that for years, if ever. CM153, which was 2nd line with nivo, is not the same setting/Q we contend w/now. https://t.co/9t4OT0d4Lq
-
-
Mashup Score: 2GRACE Glossary | CancerGRACE - 7 month(s) ago
Coming soon…
Source: cancergrace.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1The Alina Trial for ALK+ NSCLC - 7 month(s) ago
Dr. Joshua Reuss gives a brief description of the ongoing Alina trial for patients with ALK+ NSCLC.
Source: www.spreaker.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7The Burden of Lung Cancer in Women Compared With Men in the US - 7 month(s) ago
This cross-sectional study examines the incidence rates of lung cancer in women compared with men from 2000 to 2019.
Source: jamanetwork.comCategories: Hem/Oncs, Latest HeadlinesTweet
Hope the retrospective data evaluated by @LovaSunMD & colleagues was also featured in discussion. https://t.co/lXFJNM79V9 Not prospective data, but we're not going to have that for years, if ever. CM153, which was 2nd line with nivo, is not the same setting/Q we contend w/now. https://t.co/9t4OT0d4Lq